Skip to main content

previous disabled Page of 130
and
  1. Article

    Open Access

    A deep learning-driven discovery of berberine derivatives as novel antibacterial against multidrug-resistant Helicobacter pylori

    Helicobacter pylori (H. pylori) is currently recognized as the primary carcinogenic pathogen associated with gastric tumorigenesis, and its high prevalence and resistance make it difficult to tackle. A graph neur...

    **xi Guo, **aosa Zhao, ** Lu, Li** Zhao in Signal Transduction and Targeted Therapy (2024)

  2. No Access

    Article

    GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma

    Despite significantly improved clinical outcomes in EGFR-mutant lung adenocarcinoma, all patients develop acquired resistance and malignancy on the treatment of EGFR tyrosine kinase inhibitors (EGFR-TKIs). Und...

    Ning-xiang Shen, Ming-yu Luo, Wei-ming Gu, Miaomiao Gong, Hui-min Lei, Ling Bi in Oncogene (2024)

  3. Article

    Open Access

    Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression

    More than 90% of hepatocellular carcinoma (HCC) cases develop in the presence of fibrosis or cirrhosis, making the tumor microenvironment (TME) of HCC distinctive due to the intricate interplay between cancer-...

    Hao Peng, Meng Yang, Kun Feng, Qingpeng Lv in Signal Transduction and Targeted Therapy (2024)

  4. No Access

    Article

    DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression

    Type 1 insulin-like growth factor receptor (IGF1R) plays an important role in cancer, however, posttranscriptional regulation such as N6-methyladenosine (m6A) of IGF1R remains unclear. Here, we reveal a role for ...

    Ya Wen, **wang Yang, Yifei Li, Xueqing Zhao, Ao Ding, Dalong Song, Liqiang Duan in Oncogene (2024)

  5. Article

    Retraction Note: The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer

    P. Gao, A.-Y. **ng, G.-Y. Zhou, T.-G. Zhang, J.-P. Zhang, C. Gao, H. Li in Oncogene (2024)

  6. No Access

    Article

    tRF-33-P4R8YP9LON4VDP inhibits gastric cancer progression via modulating STAT3 signaling pathway in an AGO2-dependent manner

    It has been demonstrated that tRNA-derived small RNAs (tsRNAs) perform essential functions in the pathophysiology of cancer. In this study, we focused on the possible mechanisms of tRF-33-P4R8YP9LON4VDP (tRF-3...

    Shuangshuang Zhang, Yeqi Gu, Jiaxin Ge, Yaoyao **e, **uchong Yu, **nxin Wu in Oncogene (2024)

  7. No Access

    Article

    Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with macrophages to promote their dissemination

    Approximately 40% of patients with lung adenocarcinoma (LUAD) often develop bone metastases during the course of their disease. However, scarcely any in vivo model of LUAD bone metastasis has been established,...

    Zhao Wang, Zhe Lei, Yong Wang, Shengjie Wang, Jia-** Wang, Ersuo **, **a Liu in Oncogene (2024)

  8. Article

    Open Access

    Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4

    The combination of programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) antibodies has potential for enhancing clinical efficacy. We described the development and antitumor acti...

    Jianyao Zeng, Yuan Fang, Zixuan Zhang, Zhenzhen Lv, **aodie Wang, Qian Huang in Oncogene (2024)

  9. Article

    Open Access

    A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication

    The ORF9b protein, derived from the nucleocapsid’s open-reading frame in both SARS-CoV and SARS-CoV-2, serves as an accessory protein crucial for viral immune evasion by inhibiting the innate immune response. ...

    Yuzheng Zhou, Zongpeng Chen, Sijie Liu in Signal Transduction and Targeted Therapy (2024)

  10. Article

    Open Access

    Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma

    Epidermal growth factor receptor (EGFR) is reportedly overexpressed in most esophageal squamous cell carcinoma (ESCC) patients, but anti-EGFR treatments offer limited survival benefits. Our preclinical data sh...

    Yanni Wang, Chang Liu, Huan Chen, ** Jiao in Signal Transduction and Targeted Therapy (2024)

  11. Article

    Open Access

    Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity

    CD8+ T cell immune responses are regulated by multi-layer networks, while the post-translational regulation remains largely unknown. Transmembrane ectodomain shedding is an important post-translational process or...

    Lina Sun, Anjun Jiao, Haiyan Liu, Renyi Ding in Signal Transduction and Targeted Therapy (2024)

  12. Article

    Open Access

    Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer

    Pancreatic cancer is one of the deadly malignancies with a significant mortality rate and there are currently few therapeutic options for it. The tumor microenvironment (TME) in pancreatic cancer, distinguishe...

    Pengcheng Zhou, Xuanlong Du, Weilu Jia in Signal Transduction and Targeted Therapy (2024)

  13. Article

    Open Access

    Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

    Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring clonal advantage as the initial event. However, despite pervasive somatic mutations and clonal expansion in normal tis...

    Shaosen Zhang, **nyi **ao, Yonglin Yi in Signal Transduction and Targeted Therapy (2024)

  14. Article

    Open Access

    Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation

    The role of tumor-resident microbiota in modulating tumor immunity remains unclear. Here, we discovered an abundance of intra-tumoral bacteria, such us E.coli, residing and resulting in Colorectal cancer liver me...

    Jian Gu, **aozhang Xu, **angyu Li, Lei Yue, **aowen Zhu, Qiuyang Chen, Ji Gao in Oncogene (2024)

  15. No Access

    Article

    Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models

    CRPC remains a significant challenge in prostate cancer research. We aimed to elucidate the role of gut microbiota and its specific mechanisms in CRPC using a multidisciplinary approach. We analyzed 16S rRNA s...

    Guowen Lin, Feng Zhang, **aoling Weng, Zhe Hong, Dingwei Ye, Gangmin Wang in Oncogene (2024)

  16. Article

    Open Access

    METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4

    N6-methyladenosine (m6A) is the predominant post-transcriptional RNA modification in eukaryotes and plays a pivotal regulatory role in various aspects of RNA fate determination, such as mRNA stability, alternativ...

    Yichen Zang, Zhuangfei Tian, Dandan Wang, Yaxuan Li, Wenhui Zhang, Cunying Ma in Oncogene (2024)

  17. No Access

    Article

    Environmental monobutyl phthalate exposure promotes liver cancer via reprogrammed cholesterol metabolism and activation of the IRE1α-XBP1s pathway

    Humans are widely exposed to phthalates, a major chemical plasticizer that accumulates in the liver. However, little is known about the impact of chronic phthalate exposure on liver cancer development. In this...

    Tingting Zhang, Faming Zhao, Yanxia Hu, **lan Wei, Fengzhen Cui, Yahang Lin in Oncogene (2024)

  18. Article

    Open Access

    Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study

    This multicentre, two-arm, phase 2 study aimed to explore the efficacy and safety of neoadjuvant camrelizumab plus chemotherapy or apatinib in patients with initially unresectable stage II–III non-small-cell l...

    Haoran **a, Han Zhang, Zheng Ruan in Signal Transduction and Targeted Therapy (2024)

  19. Article

    Open Access

    Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents

    The herd immunity against SARS-CoV-2 is continuously consolidated across the world during the ongoing pandemic. However, the potential function of the nonconserved epitopes in the reverse preexisting cross-rea...

    **n Wang, Jie Zhang, Maoshun Liu, Yuanyuan Guo in Signal Transduction and Targeted Therapy (2024)

  20. Article

    Open Access

    DAB2IP inhibits glucose uptake by modulating HIF-1α ubiquitination under hypoxia in breast cancer

    Metabolic reprogramming has become increasingly important in tumor biology research. The glucose metabolic pathway is a major energy source and is often dysregulated in breast cancer. DAB2IP is widely reported...

    Hongliang Dong, Weiyi Jia, Weijian Meng, Rui Zhang, Zhihong Qi, Zhuo Chen in Oncogenesis (2024)

previous disabled Page of 130